Heljä L.
- Country
- Finland
- Department
- Division of Hematology-Oncology and Stem Cell Transplantation
Research Overview
- Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia
- Evaluation of Quizartinib in Combination with Chemotherapy for Pediatric FLT3-ITD Positive, NPM1 Wild-Type Acute Myeloid Leukemia
- Evaluation of Gemtuzumab Ozogamicin and Drug Combination in Pediatric Acute Myeloid Leukemia: A NOPHO-DB-SHIP Consortium Study
Data & Insights
Has run more than one trial at 98 of 189 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the treatment of acute myeloid leukemia (AML), with particular focus on pediatric and adolescent patients. Their research interests center on developing innovative therapeutic approaches for young patients with newly diagnosed AML.
- Pediatric AML Treatment Protocols
- Adolescent Leukemia Management
- CD33-positive AML Therapeutics
Their clinical expertise extends to evaluating treatment efficacy in standard-risk groups and optimizing consolidation therapy approaches for improved patient outcomes.
Pediatric Oncology
The investigator's work focuses on advancing therapeutic strategies for childhood cancer, specifically in hematological malignancies. Their expertise encompasses the development of comprehensive treatment protocols tailored to young patients.
- Early Disease Response Assessment
- Risk-Adapted Therapy
- Treatment Protocol Optimization
Their research activities aim to enhance survival rates while considering age-specific treatment requirements and responses.
Clinical Innovation
The investigator's work involves evaluating novel therapeutic approaches in pediatric blood cancers. Their research encompasses the assessment of targeted therapies and optimization of treatment protocols.
- Treatment Protocol Development
- Therapeutic Response Evaluation
- Clinical Outcomes Assessment
Their clinical focus includes investigating treatment modifications to improve efficacy while maintaining patient safety.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.